Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -0.99% | -.--% | -.--% |
Business Summary
Number of employees: 8
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Cancer Therapeutics
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,499,232 | 37,481 ( 2.500 %) | 0 | 2.500 % |
Stock B | 0 | 78,768 | 0 | 0 |
Company contact information
Poniard Pharmaceuticals, Inc.
300 Elliott Avenue West Suite 530
98119, Seattle
+
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 149 | |
-3.69% | 89.33B | |
+4.08% | 41.19B | |
-15.09% | 31.87B | |
+53.68% | 24.52B | |
-15.13% | 15.68B | |
-8.63% | 12.34B | |
-40.39% | 12.23B | |
+6.22% | 8.83B | |
-6.67% | 8.28B |
- Stock Market
- Equities
- PARD Stock
- Company Poniard Pharmaceuticals, Inc.